IDEAS home Printed from https://ideas.repec.org/a/eur/ejmnjr/84.html
   My bibliography  Save this article

Consumption of Insulins in Primary Health Care in Albania during 2010-2020

Author

Listed:
  • Laerta Kakariqi

    (Department of Biomedical and Experimental, Section of Pharmacology, Faculty of Medicine, University of Medicine in Tirana, Tirana, Albania)

Abstract

Aim: evaluation of trends in out-of-hospital utilization and to prescribe of Insulin in Albania using the Anatomic Therapeutic Chemical Classification/ Defined Daily Dose -(ATC/DDD methodology). Methods: The study was retrospective, and we analyzed the data collected from Health Insurance Institute (HII) of these drugs classes in the primary health care in Albania during 2010-2020. The data about the consumption of drugs were expressed as a number of Defined Daily Dose (DDDs) /1000 inhabitants/day. For all the period under study 2010-2020, there were collected and analyzed data of import and domestic production of drugs, which represent the real consumption of drugs in the country. These data were subsequently included in a comparative analysis with the utilization data according to the Health Insurance Institute. Results: The consumption of all insulin were 3.49-10.66 DDD/1000 inhabitants/day (respectively 2010-2020). The consumption of insulin fast-acting were 1.58-4.93 DDD/1000 inhabitants/day (respectively 2010-2020). The consumption of insulin intermediate-acting were 0.56-1.06 DDD/1000 inhabitants/day (respectively 2010-2020). The consumption of insulin intermediate-acting combined with insulin fast-acting was 1.00-1.46 DDD/1000 inhabitants/day. The consumption of insulin long-acting was 0.34-3.21 DDD/1000 inhabitants/day. Conclusions: There is an increase in Insulin use from HII covering but still low values in comparison with other countries.

Suggested Citation

  • Laerta Kakariqi, 2023. "Consumption of Insulins in Primary Health Care in Albania during 2010-2020," European Journal of Medicine and Natural Scinces Articles, Revistia Research and Publishing, vol. 6, January -.
    • Handle: RePEc:eur:ejmnjr:84
    as

    Download full text from publisher

    File URL: https://revistia.com/index.php/ejmn/article/view/6943
    Download Restriction: no
    File URL: https://revistia.com/files/articles/ejmn_v6_i1_23/Kakariqi.pdf
    Download Restriction: no
    ---><---

    More about this item

    Keywords

    Drug utilization DDD; Insulin;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eur:ejmnjr:84. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Revistia Research and Publishing (email available below). General contact details of provider: https://revistia.com/index.php/ejmn .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.